ml 9 has been researched along with Leukemia, Monocytic, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honma, Y; Kanatani, Y; Kasukabe, T; Makishima, M; Yamamoto-Yamaguchi, Y | 1 |
| Hattori, M; Honma, Y; Hozumi, M; Makishima, M; Motoyoshi, K; Sampi, K | 1 |
2 other study(ies) available for ml 9 and Leukemia, Monocytic, Acute
| Article | Year |
|---|---|
Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
Topics: Antigens, Differentiation, Myelomonocytic; Antineoplastic Agents; Azepines; Base Sequence; Calcitriol; Cell Differentiation; Cytarabine; Daunorubicin; Dexamethasone; DNA Primers; Enzyme Inhibitors; Gene Expression; Genes, jun; Genes, myc; Glucocorticoids; Humans; Leukemia, Monocytic, Acute; Molecular Sequence Data; Monocytes; Myosin-Light-Chain Kinase; RNA, Messenger; Time Factors; Transcription Factor AP-1; Tumor Cells, Cultured | 1996 |
Induction of differentiation of human leukemia cells by inhibitors of myosin light chain kinase.
Topics: Azepines; Cell Differentiation; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Promyelocytic, Acute; Muramidase; Myosin-Light-Chain Kinase; Naphthalenes; Nitroblue Tetrazolium; Oxidation-Reduction; Tumor Cells, Cultured | 1991 |